Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Assets (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Assets for 6 consecutive years, with 0.59% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Assets fell 26.0% to 0.59% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.59%, a 26.0% decrease, with the full-year FY2024 number at 0.46%, down 9.0% from a year prior.
  • Return on Assets was 0.59% for Q1 2025 at Pliant Therapeutics, down from 0.37% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.25% in Q2 2023 to a low of 0.59% in Q1 2025.
  • A 5-year average of 0.35% and a median of 0.33% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -43bps in 2021, then rose 21bps in 2023.
  • Pliant Therapeutics' Return on Assets stood at 0.43% in 2021, then grew by 21bps to 0.34% in 2022, then rose by 9bps to 0.31% in 2023, then dropped by -20bps to 0.37% in 2024, then plummeted by -60bps to 0.59% in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Return on Assets are 0.59% (Q1 2025), 0.37% (Q2 2024), and 0.33% (Q1 2024).